RESUMEN
BACKGROUND AND STUDY AIM: Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are being used increasingly to treat superficial oropharyngeal and hypopharyngeal carcinomas. The aim of this study was to clarify whether ESD provided better results than EMR for en bloc and complete resection of superficial pharyngeal carcinomas. PATIENTS AND METHODS: A total of 76 superficial pharyngeal carcinomas in 59 consecutively treated patients were included. Patients underwent either conventional EMR (using a transparent cap or strip biopsy) (n = 45 lesions) or ESD (n = 31 lesions) between October 2006 and January 2011. The rates of en bloc resection, complete resection (defined as en bloc resection with tumor-free margins), major complications, and local recurrence were evaluated retrospectively as the therapeutic outcomes. RESULTS: ESD yielded significantly higher rates of both en bloc and complete resection compared with EMR (en bloc 77.4 % [24/31] vs. 37.8 % [17/45], P = 0.0002; complete 54.8 % [17/31] vs. 28.9 % [13/45], P = 0.0379). ESD was more frequently complicated by severe laryngeal edema (4/21 [19.0 %] vs. 1/31 [3.2 %], P = 0.1446) and was also more time-consuming (124.9 ± 65.1 minutes vs. 57.2 ± 69.6 minutes; P = 0.0014). Local recurrence was observed more often after EMR than after ESD (3/45 [6.7 %] vs. 0/31 [0 %]), although this difference did not reach statistical significance (P = 0.2658). CONCLUSIONS: ESD appears to be a superior method of endoscopic resection of superficial pharyngeal carcinomas for achieving both en bloc and complete resection, although these benefits were also associated with a higher incidence of complications and a significantly longer procedure time. Large prospective studies are needed to compare ESD with conventional EMR for superficial pharyngeal carcinomas.
Asunto(s)
Carcinoma/cirugía , Endoscopía del Sistema Digestivo/métodos , Membrana Mucosa/cirugía , Recurrencia Local de Neoplasia/etiología , Neoplasias Faríngeas/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma/patología , Disección/efectos adversos , Edema/etiología , Femenino , Humanos , Estimación de Kaplan-Meier , Laringe , Tiempo de Internación , Masculino , Persona de Mediana Edad , Neoplasias Faríngeas/patología , Estudios Retrospectivos , Estadísticas no Paramétricas , Factores de TiempoRESUMEN
BACKGROUND AND STUDY AIM: Endoscopic submucosal dissection (ESD) of undifferentiated-type early gastric cancer (UD-EGC) is technically feasible; however, the long-term clinical outcomes of the procedure have not yet been fully investigated. The aim of our study was to elucidate long-term outcomes of ESD for UD-EGC. PATIENTS AND METHODS: Between September 2003 and October 2009, a total of 153 patients were diagnosed endoscopically as having UD-EGC fulfilling the expanded criteria for ESD. After informed consent was obtained, 101 patients were selected to undergo ESD and 52 to undergo surgical operation. We assessed the clinical outcomes of ESD in 101 consecutive patients with 103 UD-EGC lesions who were undergoing ESD for the first time. The overall mortality and disease-free survival rates after ESD were evaluated as the long-term outcomes. RESULTS: The rates of en bloc and curative resection were 99.0% (102/103) and 82.5% (85/103), respectively. We encountered one patient with nodal metastasis detected by computed tomography before diagnostic ESD, although curative resection of the primary lesion was achieved based on routine histological examination. Among the 78 patients without a past history of malignancy within the previous 5 years in whom curative resection of the primary lesion was achieved, no cases of local recurrence or distant metastasis were observed during follow-up; however, 1 synchronous and 2 metachronous lesions were detected in 2 patients (2.6%) after primary ESD. Thus, estimated over a median follow-up period of 40.0 months (range 19-92 months) and 36.0 months (range 9-92 months), the 3-and 5-year overall mortality rates were 1.9% and 3.9%, respectively, and the 3-and 5-year overall disease-free survival rates were both 96.7%. CONCLUSIONS: Although our single-center retrospective study may be considered to be only preliminary, our data indicate that ESD for UD-EGC may yield good long-term outcomes.
Asunto(s)
Mucosa Gástrica/cirugía , Gastroscopía/métodos , Neoplasias Gástricas/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Estudios de Seguimiento , Mucosa Gástrica/patología , Humanos , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias , Estudios Retrospectivos , Neoplasias Gástricas/mortalidad , Neoplasias Gástricas/patología , Análisis de Supervivencia , Tasa de Supervivencia , Resultado del TratamientoRESUMEN
The male Wistar Bonn/Kobori (WBN/Kob) rat is known to be a unique animal model for chronic pancreatitis with widely distributed fibrosis and degeneration of parenchyma because of the infiltration of lymphocytes. In this report, we show that female (but not male) rats develop dacryoadenitis at 3 months of age, and that both male and female WBN/Kob rats develop sialoadenitis, thyroiditis, sclerotic cholangitis and tubulointerstitial nephritis over 18 months of age. The infiltration of CD8+ cells and the deposits of tissue-specific IgG2b were observed in the injured pancreas and lachrymal glands. Furthermore, the number of regulatory T cells (defined as CD4+ Forkhead box P3+ cells) decreased in the periphery of both male and female WBN/Kob rats, suggesting that the onset of these diseases is attributable, at least, to the failure in the maintenance of peripheral immune tolerance. These features show clearly that WBN/Kob rats are a useful animal model for autoimmune pancreatitis and Sjøgren-like syndrome or multi-focal fibrosclerosis in humans. We also show that these autoimmune diseases can be prevented by a newly devised strategy of bone marrow transplantation (BMT) in which bone marrow cells are injected directly into the bone marrow cavity: intrabone marrow-BMT.
Asunto(s)
Enfermedades Autoinmunes/patología , Dacriocistitis/patología , Modelos Animales de Enfermedad , Pancreatitis Crónica/patología , Animales , Enfermedades Autoinmunes/inmunología , Enfermedades Autoinmunes/prevención & control , Trasplante de Médula Ósea/métodos , Linfocitos T CD4-Positivos/patología , Linfocitos T CD8-positivos/patología , Dacriocistitis/inmunología , Dacriocistitis/prevención & control , Femenino , Técnicas para Inmunoenzimas , Inmunoglobulina G/biosíntesis , Riñón/patología , Hígado/patología , Masculino , Pancreatitis Crónica/inmunología , Pancreatitis Crónica/prevención & control , Ratas , Ratas Endogámicas F344 , Ratas Wistar , Glándula Tiroides/patologíaRESUMEN
Granulocytes from human peripheral blood were co-cultured with conventional dendritic cells (cDC) or plasmacytoid DCs (pDC) to examine the effects of DCs on the activation or function of granulocytes. After co-culture of granulocytes with DCs, expression of the activation markers of granulocytes (CD63 and CD64) was up-regulated, and increased expression of CD50, the activation marker and ligand for CD209 (DC-SIGN) was also observed. The interaction of granulocytes with DCs was visualized as the cluster where DCs, especially cDCs, were surrounded by granulocytes to form a 'rosette'. After co-culture of granulocytes with cDCs, the secretion of elastase from granulocytes was enhanced significantly when examined cytohistochemically and by enzyme-linked immunosorbent assay. An increase in myeloperoxidase (another activation index of granulocytes) was also observed after co-culture with DCs. These findings suggest the functional and phenotypical activation of granulocytes by interaction with DCs. Furthermore, we examined the involvement of adhesion molecules in the granulocyte-DC interaction, and found that CD209 participates to some extent in this interaction.
Asunto(s)
Células Dendríticas/inmunología , Granulocitos/inmunología , Antígenos CD/metabolismo , Comunicación Celular , Técnicas de Cocultivo , Granulocitos/enzimología , Humanos , Inmunofenotipificación , Elastasa Pancreática/metabolismo , Glicoproteínas de Membrana Plaquetaria/metabolismo , Receptores de IgG/metabolismo , Formación de Roseta , Tetraspanina 30 , Regulación hacia ArribaRESUMEN
The efficacy of the local application of recombinant human fibroblast growth factor-2 (FGF-2) in periodontal regeneration has been investigated. In this study, a randomized, double-blind, placebo-controlled clinical trial was conducted in 253 adult patients with periodontitis. Modified Widman periodontal surgery was performed, during which 200 µL of the investigational formulation containing 0% (vehicle alone), 0.2%, 0.3%, or 0.4% FGF-2 was administered to 2- or 3-walled vertical bone defects. Each dose of FGF-2 showed significant superiority over vehicle alone (p < 0.01) for the percentage of bone fill at 36 wks after administration, and the percentage peaked in the 0.3% FGF-2 group. No significant differences among groups were observed in clinical attachment regained, scoring approximately 2 mm. No clinical safety problems, including an abnormal increase in alveolar bone or ankylosis, were identified. These results strongly suggest that topical application of FGF-2 can be efficacious in the regeneration of human periodontal tissue that has been destroyed by periodontitis.
Asunto(s)
Factor 2 de Crecimiento de Fibroblastos/uso terapéutico , Regeneración Tisular Guiada Periodontal/métodos , Periodontitis/cirugía , Adulto , Pérdida de Hueso Alveolar/diagnóstico por imagen , Pérdida de Hueso Alveolar/cirugía , Proceso Alveolar/efectos de los fármacos , Índice de Placa Dental , Método Doble Ciego , Femenino , Factor 2 de Crecimiento de Fibroblastos/administración & dosificación , Estudios de Seguimiento , Encía/patología , Hemorragia Gingival/clasificación , Recesión Gingival/clasificación , Humanos , Masculino , Persona de Mediana Edad , Pérdida de la Inserción Periodontal/clasificación , Índice Periodontal , Ligamento Periodontal/efectos de los fármacos , Bolsa Periodontal/clasificación , Placebos , Radiografía , Proteínas Recombinantes , Colgajos Quirúrgicos , Movilidad Dentaria/clasificación , Resultado del TratamientoRESUMEN
Left atrial myocardial tissues, excised at the time of surgery from 30 Japanese patients, were studied using light and electron microscopy and the freeze-fracture technique. All had mitral valvular disease, and, in 22 (74%) patients, atrial fibrillation also was present. In all patients, most of the left atrial cardiocytes were hypertrophied and surrounded by various amounts of fibrous tissue. Degenerative alterations included large masses of lipofuscin granules and lamellar bodies, disorganized myofibrils, widened Z-line material, selective loss of thick filaments, and prominent tubules of sarcoplasmic reticulum. A high incidence of tubular aggregates was observed in 70% of the cases. Such alterations were seen more often in the mitral regurgitation group as compared to the mitral stenosis group. Atrial cardiocytes were found to be more susceptible to disease processes, such as rheumatic fever and subsequent pressure and/or volume overloading, than ventricular cardiocytes. Human atrial cardiocytes may be utilized in future cytopathological studies to study the effect of processes leading to cardiocyte hypertrophy and degeneration.